research-triangle-park
(3)
Eric Bolesh
Eric Bolesh is the Chief Executive Officer of Cutting Edge Information, a Research Triangle Park firm that has become the de facto industry standard for fair market value (FMV) data in life sciences. One of the company's first employees back in 2002, he spent two decades turning the murky question of what a cardiologist in Bulgaria or a pharmacist in the UK should be paid into a defensible, data-driven discipline. A Harvard graduate and frequent speaker at compliance conferences, he is widely regarded as a thought leader on healthcare-provider engagement and the economics of compliant compensation across more than 130 global markets.
Michael Milburn
Michael V. Milburn is the CEO and President of GeneCentric Therapeutics, a Durham, North Carolina biotech building RNA-based liquid biopsy tools that read a tumor's behavior from a single tube of blood. A structural biologist by training, he helped solve the first crystal structures of the Ras cancer protein at Berkeley in the late 1980s, then spent decades building research engines at Sirtris, Plexxikon, and Metabolon before taking the top job at GeneCentric in 2019. His current bet: that the fragments of DNA shed by tumors carry enough information to infer gene expression, not just mutations, turning a blood draw into a near-complete molecular portrait of cancer.
Robert Mallernee
Robert Mallernee is the founder and CEO of Eton Solutions, the Research Triangle Park company behind AtlasFive, an integrated, cloud-native, AI-driven platform that runs the back office for more than 1,000 of the world's wealthiest families. A CFA with three-plus decades in ultra-high-net-worth wealth management, he built the software inside a real multi-family office (Eton Advisors) before spinning it out to sell to the rest of the industry. His pitch is blunt: spreadsheets are 'separate-sheets,' and the modern family office needs one system, not a hundred. In 2025 Eton closed a $58M Series C to push AtlasFive and EtonAI deeper into private equity, funds and global private banks.